Cargando…
Methodology of drug screening and target identification for new necroptosis inhibitors
Apoptosis has been considered as the only form of regulated cell death for a long time. However, a novel form of programmed cell death called necroptosis was recently reported. The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human disea...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460297/ https://www.ncbi.nlm.nih.gov/pubmed/31011462 http://dx.doi.org/10.1016/j.jpha.2018.11.002 |
_version_ | 1783410307637444608 |
---|---|
author | Pan, Pengchao Cai, Zhenyu Zhuang, Chunlin Chen, Xiaofei Chai, Yifeng |
author_facet | Pan, Pengchao Cai, Zhenyu Zhuang, Chunlin Chen, Xiaofei Chai, Yifeng |
author_sort | Pan, Pengchao |
collection | PubMed |
description | Apoptosis has been considered as the only form of regulated cell death for a long time. However, a novel form of programmed cell death called necroptosis was recently reported. The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human diseases. Thus, the study on the molecular mechanism of necroptosis and its effective inhibitors has been an attractive field for researchers. Herein, we introduce the molecular mechanism of necroptosis and focus on the literature about necroptosis drug screening in recent years. In addition, the identification of the critical drug targets of the necroptosis is also discussed. |
format | Online Article Text |
id | pubmed-6460297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Xi'an Jiaotong University |
record_format | MEDLINE/PubMed |
spelling | pubmed-64602972019-04-22 Methodology of drug screening and target identification for new necroptosis inhibitors Pan, Pengchao Cai, Zhenyu Zhuang, Chunlin Chen, Xiaofei Chai, Yifeng J Pharm Anal Review Paper Apoptosis has been considered as the only form of regulated cell death for a long time. However, a novel form of programmed cell death called necroptosis was recently reported. The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human diseases. Thus, the study on the molecular mechanism of necroptosis and its effective inhibitors has been an attractive field for researchers. Herein, we introduce the molecular mechanism of necroptosis and focus on the literature about necroptosis drug screening in recent years. In addition, the identification of the critical drug targets of the necroptosis is also discussed. Xi'an Jiaotong University 2019-04 2018-11-27 /pmc/articles/PMC6460297/ /pubmed/31011462 http://dx.doi.org/10.1016/j.jpha.2018.11.002 Text en © 2018 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Paper Pan, Pengchao Cai, Zhenyu Zhuang, Chunlin Chen, Xiaofei Chai, Yifeng Methodology of drug screening and target identification for new necroptosis inhibitors |
title | Methodology of drug screening and target identification for new necroptosis inhibitors |
title_full | Methodology of drug screening and target identification for new necroptosis inhibitors |
title_fullStr | Methodology of drug screening and target identification for new necroptosis inhibitors |
title_full_unstemmed | Methodology of drug screening and target identification for new necroptosis inhibitors |
title_short | Methodology of drug screening and target identification for new necroptosis inhibitors |
title_sort | methodology of drug screening and target identification for new necroptosis inhibitors |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460297/ https://www.ncbi.nlm.nih.gov/pubmed/31011462 http://dx.doi.org/10.1016/j.jpha.2018.11.002 |
work_keys_str_mv | AT panpengchao methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors AT caizhenyu methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors AT zhuangchunlin methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors AT chenxiaofei methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors AT chaiyifeng methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors |